Pradaxa Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Status Conference in Federal Pradaxa Litigation

The Firm is evaluating legal claims on behalf of alleged victims of Pradaxa bleeding side effects.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Free Case Review
We are continuing to investigate product liability claims on behalf of alleged victims of Pradaxa bleeding side effects. We look forward to more progress in this litigation.

New York, New York (PRWEB) December 15, 2013

Nearly 2,000 Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/ ) continue to move forward in a multidistrict litigation now underway in U.S. District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. According to court documents, the proceeding's next Status Conference will be held on December 20, 2013 at 3:30 p.m. This month’s conference will be conducted via teleconference. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)

“We are continuing to investigate product liability claims on behalf of alleged victims of Pradaxa bleeding side effects. We look forward to more progress in this litigation,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Pradaxa lawsuit evaluations to individuals who suffered serious internal bleeding while using this blood thinner.

Pradaxa Lawsuits
According to court documents, 1,952 Pradaxa lawsuits are now pending in the proceeding underway in Illinois federal court. All of the lawsuits allege that Boehringer Ingelheim failed to provide adequate warnings regarding the risk of serious Pradaxa bleeding, including the fact that there currently exists no effective antidote to reverse this potential side effect. In November, the Court established a protocol for selecting bellwether cases for the litigation’s first trials. Those trials are scheduled to begin in August 2014.

The Institute for Safe Medicine Practices reported in October that last year alone, the U.S. Food & Drug Administration (FDA) received 3,200 reports of Pradaxa adverse events, more than any other drug tracked by the agency. Furthermore, the reports included 582 that had fatal outcomes. The same year, warfarin, a much older blood thinner that Pradaxa was supposed to replace, was the subject of just 861 reports, including 56 deaths. Among other things, the ISMP cited the lack of an antidote to reverse the drug’s anticoagulant effects as one possible reason for these numbers.*

Alleged victims of Pradaxa bleeding side effects may be entitled to financial damages for their medical bills, lost wages, pain and suffering, and more. To find out more about filing a Pradaxa lawsuit, please visit Bernstein Liebhard LLP’s website. For a free case review, please call 800-511-5092.

*ismp.org/QuarterWatch/pdfs/2012Q4.pdf, ISMP, October 17, 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.pradaxalawsuithelp.com/
https://plus.google.com/115936073311125306742?rel=author